Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men (PSA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00761124|
Recruitment Status : Active, not recruiting
First Posted : September 29, 2008
Last Update Posted : May 7, 2019
The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening.
The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge.
The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county.
Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview.
The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.
|Condition or disease||Intervention/treatment||Phase|
|Prostate Cancer||Behavioral: Intervention Session Behavioral: Printed Material||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1006 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Informed Decision-Making Regarding PSA Screening|
|Actual Study Start Date :||April 2003|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||December 2020|
Educational small group session regarding prostate cancer
Behavioral: Intervention Session
A one-hour discussion group composed of 8-10 Latino men. The session includes an interactive, multimedia presentation led by a facilitator to guide participant interaction.
Printed material regarding general prostate cancer information provided.
Behavioral: Printed Material
General prostate cancer pamphlet
- Inform Decision-Making [ Time Frame: 6 months post-baseline interview ]
- Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers [ Time Frame: 6 months post-baseline interview ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00761124
|United States, California|
|UCLA, Division of Cancer Prevention and Control Research|
|Los Angeles, California, United States, 90095|
|Principal Investigator:||Roshan Bastani, PhD||University of California, Los Angeles|